Future combined vaccines

被引:4
作者
Begue, P
Grimprel, E
机构
关键词
D O I
10.1093/infdis/174.Supplement_3.S295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The increasing number of useful vaccines for infants and children justifies the development of new combined vaccines. New methodologies are needed for evaluation of efficacy, especially for acellular pertussis vaccines. Such evaluation requires the use of previous immunogenicity studies as a means to seek immune interference that might lead to decreased efficacy. Finally, definitive efficacy could be assessed by long-term postmarketing epidemiologic surveillance. Different combinations are discussed in relation to age of recipients (infants, children) adolescents, and adults) and national or regional epidemiologies.
引用
收藏
页码:S295 / S297
页数:3
相关论文
共 11 条
[1]  
*AM ACAD PED, 1992, PEDIATRICS, V1, P121
[2]   HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE-TETANUS PROTEIN CONJUGATE VACCINE DOES NOT DEPRESS SEROLOGIC RESPONSES TO DIPHTHERIA, TETANUS OR PERTUSSIS ANTIGENS WHEN COADMINISTERED IN THE SAME SYRINGE WITH DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AT 2, 4 AND 6 MONTHS OF AGE [J].
AVENDANO, A ;
FERRECCIO, C ;
LAGOS, R ;
HORWITZ, I ;
CAYAZZO, M ;
FRITZELL, B ;
MESCHIEVITZ, C ;
LEVINE, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (08) :638-643
[3]   COMBINATION VACCINES - HOPES AND CHALLENGES [J].
EDWARDS, KM ;
DECKER, MD .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) :345-347
[4]  
EDWARDS KM, 1993, J INFECT DIS, V168, P15, DOI 10.1093/infdis/168.1.15
[5]   THE CLINICAL AND IMMUNOLOGICAL RESPONSE OF CHILEAN INFANTS TO HAEMOPHILUS-INFLUENZAE TYPE B-POLYSACCHARIDE-TETANUS PROTEIN CONJUGATE VACCINE COADMINISTERED IN THE SAME SYRINGE WITH DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS VACCINE AT 2, 4 AND 6 MONTHS OF AGE [J].
FERRECCIO, C ;
CLEMENS, J ;
AVENDANO, A ;
HORWITZ, I ;
FLORES, C ;
AVILA, L ;
CAYAZZO, M ;
FRITZELL, B ;
CADOZ, M ;
LEVINE, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (10) :764-771
[6]   A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis [J].
Greco, D ;
Salmaso, S ;
Mastrantonio, P ;
Giuliano, M ;
Tozzi, AE ;
Anemona, A ;
Atti, MLCD ;
Giammanco, A ;
Panei, P ;
Blackwelder, WC ;
Klein, DL ;
Wassilak, SGF ;
Stefanelli, P ;
Bottone, M ;
Sofia, T ;
Luzi, S ;
Bellomi, G ;
Cobianchi, F ;
Canganella, G ;
Meduri, F ;
Scuderi, G ;
Chiarini, A ;
Maggio, M ;
Taormina, S ;
Genovese, M ;
Moiraghi, A ;
Barale, A ;
DiTommaso, S ;
Malaspina, S ;
Vasile, E ;
Ferraro, P ;
DalLago, P ;
DeMarzi, L ;
Robino, L ;
Giraldo, E ;
Coppola, N ;
Materassi, P ;
Castellani, GT ;
Basso, F ;
Barbuti, S ;
Quarto, M ;
Lopalco, P ;
DOrazio, P ;
Sanguedolce, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :341-348
[7]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355
[8]  
*I SUP SAN, 1995, INT S PERT VACC TRIA
[9]   SIMULTANEOUS ADMINISTRATION OF CHILDHOOD VACCINES - AN IMPORTANT PUBLIC-HEALTH POLICY THAT IS SAFE AND EFFICACIOUS [J].
KING, GE ;
HADLER, SC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) :394-407
[10]   A PLACEBO-CONTROLLED TRIAL OF A PERTUSSIS-TOXOID VACCINE [J].
TROLLFORS, B ;
TARANGER, J ;
LAGERGARD, T ;
LIND, L ;
SUNDH, V ;
ZACKRISSON, G ;
LOWE, CU ;
BLACKWELDER, W ;
ROBBINS, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (16) :1045-1050